Related Experiment Videos
Economic evaluation studies in nuclear medicine: the need for standardization
M Dietlein1, W H Knapp, K W Lauterbach
1Department of Nuclear Medicine, University of Cologne, Germany.
European Journal of Nuclear Medicine
|June 17, 1999
Summary
Economic evaluations in nuclear medicine guide healthcare decisions by assessing cost-effectiveness. Key elements include specifying interventions, outcomes, and uncertainties for reliable analysis.
Area of Science:
- Health Economics
- Nuclear Medicine
- Decision Analysis
Background:
- Economic evaluations are crucial for publishing healthcare analyses, requiring clear statements on economic importance and viewpoint.
- Key components include defining alternative interventions, evaluation methods, outcome measures, costing, time horizon, and uncertainty analysis.
Purpose of the Study:
- To outline the essential components for conducting and publishing economic evaluations in healthcare.
- To highlight the significance of outcome measures and provide examples of economic evaluations in nuclear medicine.
Main Methods:
- Decision analysis based on clinical trial data, databases, or modeling.
- Cost-effectiveness analysis, often using natural units for benefits, is prevalent in nuclear medicine.
- Utilizing various endpoints like procedures avoided, survival probability, quality of life, and surrogate markers.
Main Results:
- Nuclear medicine commonly employs cost-effectiveness analysis with natural units.
- Examples demonstrate the application of economic evaluations for FDG-PET, scintigraphy, and radioiodine therapy.
- Surrogate endpoints limit comparability; quality-adjusted life years (QALYs) are less frequently used.
Conclusions:
- Standardized reporting of economic evaluations ensures clarity and comparability.
- Nuclear medicine studies benefit from robust economic evaluations to inform clinical practice and guidelines.
- Multidisciplinary collaboration is essential for integrating nuclear medicine procedures into management guidelines.